Observational studyGlaucoma
ELIOS with phaco: 24-month pivotal study published
A prospective multicentre, non-randomised device trial reports 24-month outcomes in 318 patients with glaucoma and cataract.
Why it matters
Relevant to the evidence map for combined cataract and glaucoma procedures.
Keep in mind
No concurrent randomised control arm; prespecified performance goals are not equivalent to a direct comparison. No practice-change recommendation.
- Study design
- Non-randomised prospective trial
- Sample
- 318 patients